Literature DB >> 19830572

The course and outcomes of episodic endogenous psychoses with juvenile onset (a follow-up study).

V G Kaleda1.   

Abstract

A clinical follow-up study (mean follow-up period 16.8 +/- 6.4 years) of 278 patients with juvenile-onset endogenous episodic psychosis (Endogenous Psychosis Episodic Type, EPET -- ICD-10 F20.03, F20.23, F25) with first episodes in 1984-1995 was performed. The period of the most intense occurrence of repeated episodes occurred during the first five years from the initial episode (almost all repeat episodes in the patients occurred during this period). At the time of the follow-up study, "good" outcomes were seen in 18.7% of patients, "relatively good" in 33.8%, "relatively poor" in 30.2%, and "poor" in 17.2%. Analysis of correlations between disease course and outcome and types of manifest episode and a number of clinical-pathogenetic parameters yielded several statistically significant criteria for clinical and social prognosis. Nosological evaluation at the time of the follow-up study showed that 76.2% of patients had schizophrenia (episodic progressive in 61.1%, recurrent in 15.1%) and 28.3% had schizoaffective psychosis. Comparison of the data with results from previous analogous studies led to the conclusion that the contemporary pathomorphosis of EPET is more favorable, with trends to improvements in disease course and outcome, decreases in progression, and significant reductions in cases of transition to a chronic course.

Entities:  

Mesh:

Year:  2009        PMID: 19830572     DOI: 10.1007/s11055-009-9208-5

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  38 in total

1.  Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders.

Authors:  M Jäger; R Bottlender; A Strauss; H-J Möller
Journal:  Acta Psychiatr Scand       Date:  2004-01       Impact factor: 6.392

2.  Measuring schizophrenia remission in clinical practice.

Authors:  Jordi Alonso; Antonio Ciudad; Alfonso Casado; Inmaculada Gilaberte
Journal:  Can J Psychiatry       Date:  2008-03       Impact factor: 4.356

Review 3.  Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies.

Authors:  R Grant Steen; Courtney Mull; Robert McClure; Robert M Hamer; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2006-06       Impact factor: 9.319

4.  [Features of the premorbid states of patients with juvenile schizophrenia (a comparative clinical study)].

Authors:  L G Pekunova
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1974

5.  [Several features of the course of attack-like schizophrenia (according to the findings of an epidemiologic study)].

Authors:  L M Shmaonova; Iu I Liberman
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1979

6.  Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale.

Authors:  Sarah van Mastrigt; Jean Addington
Journal:  J Psychiatry Neurosci       Date:  2002-03       Impact factor: 6.186

7.  Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

Authors:  D Wiersma; F J Nienhuis; C J Slooff; R Giel
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

8.  Long-term course of schizophrenic illness: Bleuler's study reconsidered.

Authors:  Jiri Modestin; Andreas Huber; Engin Satirli; Tina Malti; Daniel Hell
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

Review 9.  Course and long-term treatment of schizophrenic psychoses.

Authors:  H-J Möller
Journal:  Pharmacopsychiatry       Date:  2004-11       Impact factor: 5.788

10.  Clinical course and outcome of schizophrenia in Cali, Colombia. A 10-year follow-up study.

Authors:  C A León
Journal:  J Nerv Ment Dis       Date:  1989-10       Impact factor: 2.254

View more
  1 in total

1.  Patterns of illness and care over the 5 years following onset of psychosis in different ethnic groups; the GAP-5 study.

Authors:  Olesya Ajnakina; John Lally; Marta Di Forti; Anna Kolliakou; Poonam Gardner-Sood; Javier Lopez-Morinigo; Paola Dazzan; Carmine M Pariante; Valeria Mondelli; James MacCabe; Anthony S David; Fiona Gaughran; Robin M Murray; Evangelos Vassos
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-07-05       Impact factor: 4.328

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.